Hospitals Threaten Legal Action Over CMS’s Decision To Slash Lucrative Drug Subsidies
Critics of the 340B program, designed to help hospitals with large numbers of uninsured patients, say the significant margin on the drugs gives hospitals an incentive to overuse certain drugs or choose high-priced options.